ArticleOncology letters2018

Dioscin suppresses the viability of ovarian cancer cells by regulating the VEGFR2 and PI3K/AKT/MAPK signaling pathways.

Xianqing Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.